{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T06:32:15Z","timestamp":1794983535517,"version":"4.9.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-63791-7","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:05:52Z","timestamp":1759233952000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Keratinocyte-specific H4K12 lactylation drives a non-canonical IL-17-dependent signaling in psoriasis progression in mice"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5489-579X","authenticated-orcid":false,"given":"Xuecheng","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxuan","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2731-1912","authenticated-orcid":false,"given":"Qiong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3530-9855","authenticated-orcid":false,"given":"Qiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"63791_CR1","doi-asserted-by":"publisher","first-page":"912","DOI":"10.3899\/jrheum.141271","volume":"42","author":"K Pavelka","year":"2015","unstructured":"Pavelka, K. et al. A study to evaluate the safety, tolerability, and efficacy of brodalumab in subjects with rheumatoid arthritis and an inadequate response to methotrexate. J. Rheumatol. 42, 912\u2013919 (2015).","journal-title":"J. Rheumatol."},{"key":"63791_CR2","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s00415-016-8128-x","volume":"263","author":"E Havrdova","year":"2016","unstructured":"Havrdova, E. et al. Activity of secukinumab, an anti-IL-17A antibody, on brain lesions in RRMS: results from a randomized, proof-of-concept study. J. Neurol. 263, 1287\u20131295 (2016).","journal-title":"J. Neurol."},{"key":"63791_CR3","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","volume":"61","author":"W Hueber","year":"2012","unstructured":"Hueber, W. et al. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn\u2019s disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut 61, 1693\u20131700 (2012).","journal-title":"Gut"},{"key":"63791_CR4","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/ajg.2016.298","volume":"111","author":"SR Targan","year":"2016","unstructured":"Targan, S. R. et al. A randomized, double-blind, placebo-controlled phase 2 study of brodalumab in patients with moderate-to-severe Crohn\u2019s Disease. Am. J. Gastroenterol. 111, 1599\u20131607 (2016).","journal-title":"Am. J. Gastroenterol."},{"key":"63791_CR5","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","volume":"397","author":"K Ghoreschi","year":"2021","unstructured":"Ghoreschi, K., Balato, A., Enerback, C. & Sabat, R. Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis. Lancet 397, 754\u2013766 (2021).","journal-title":"Lancet"},{"key":"63791_CR6","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1016\/j.immuni.2023.06.012","volume":"56","author":"Q Luo","year":"2023","unstructured":"Luo, Q. et al. An autonomous activation of interleukin-17 receptor signaling sustains inflammation and promotes disease progression. Immunity 56, 2006\u20132020 (2023).","journal-title":"Immunity"},{"key":"63791_CR7","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths, C. E. M., Armstrong, A. W., Gudjonsson, J. E. & Barker, J. Psoriasis. Lancet 397, 1301\u20131315 (2021).","journal-title":"Lancet"},{"key":"63791_CR8","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.jaci.2021.04.021","volume":"148","author":"J Kim","year":"2021","unstructured":"Kim, J. et al. Single-cell transcriptomics applied to emigrating cells from psoriasis elucidate pathogenic versus regulatory immune cell subsets. J. Allergy Clin. Immunol. 148, 1281\u20131292 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"key":"63791_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/srt.13550","volume":"30","author":"J Pan","year":"2024","unstructured":"Pan, J. et al. Use of biologics in patients with psoriasis - A retrospective analysis based on real-world data. Ski. Res. Technol. 30, e13550 (2024).","journal-title":"Ski. Res. Technol."},{"key":"63791_CR10","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong, A. W. & Read, C. Pathophysiology, clinical presentation, and treatment of psoriasis: A review. JAMA 323, 1945\u20131960 (2020).","journal-title":"JAMA"},{"key":"63791_CR11","doi-asserted-by":"publisher","first-page":"e2250279","DOI":"10.1002\/eji.202250279","volume":"54","author":"X Wang","year":"2024","unstructured":"Wang, X. & Lai, Y. Keratinocytes in the pathogenesis, phenotypic switch, and relapse of psoriasis. Eur. J. Immunol. 54, e2250279 (2024).","journal-title":"Eur. J. Immunol."},{"key":"63791_CR12","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/ni.2080","volume":"12","author":"K Bulek","year":"2011","unstructured":"Bulek, K. et al. The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation. Nat. Immunol. 12, 844\u2013852 (2011).","journal-title":"Nat. Immunol."},{"key":"63791_CR13","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/ni.2081","volume":"12","author":"D Sun","year":"2011","unstructured":"Sun, D. et al. Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF). Nat. Immunol. 12, 853\u2013860 (2011).","journal-title":"Nat. Immunol."},{"key":"63791_CR14","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.3389\/fimmu.2018.01682","volume":"9","author":"NC Brembilla","year":"2018","unstructured":"Brembilla, N. C., Senra, L. & Boehncke, W. H. The IL-17 family of cytokines in psoriasis: IL-17A and beyond. Front. Immunol. 9, 1682 (2018).","journal-title":"Front. Immunol."},{"key":"63791_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s12016-018-8702-3","volume":"55","author":"A Blauvelt","year":"2018","unstructured":"Blauvelt, A. & Chiricozzi, A. The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis. Clin. Rev. Allergy Immunol. 55, 379\u2013390 (2018).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"63791_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jaci.2012.04.024","volume":"130","author":"JG Krueger","year":"2012","unstructured":"Krueger, J. G. et al. IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis. J. Allergy Clin. Immunol. 130, 145\u2013154.e149 (2012).","journal-title":"J. Allergy Clin. Immunol."},{"key":"63791_CR17","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.jaci.2019.04.029","volume":"144","author":"JG Krueger","year":"2019","unstructured":"Krueger, J. G. et al. IL-17A inhibition by secukinumab induces early clinical, histopathologic, and molecular resolution of psoriasis. J. Allergy Clin. Immunol. 144, 750\u2013763 (2019).","journal-title":"J. Allergy Clin. Immunol."},{"key":"63791_CR18","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.jid.2019.01.006","volume":"139","author":"S Moos","year":"2019","unstructured":"Moos, S., Mohebiany, A. N., Waisman, A. & Kurschus, F. C. Imiquimod-induced psoriasis in mice depends on the IL-17 signaling of keratinocytes. J. Invest. Dermatol. 139, 1110\u20131117 (2019).","journal-title":"J. Invest. Dermatol."},{"key":"63791_CR19","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1001\/jamadermatol.2024.0257","volume":"160","author":"RC Velasco","year":"2024","unstructured":"Velasco, R. C. et al. Guselkumab for Pityriasis Rubra Pilaris and dysregulation of IL-23\/IL-17 and NFkB signaling: A nonrandomized trial. JAMA Dermatol. 160, 641\u2013645 (2024).","journal-title":"JAMA Dermatol."},{"key":"63791_CR20","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0140-6736(15)60125-8","volume":"386","author":"CE Griffiths","year":"2015","unstructured":"Griffiths, C. E. et al. Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials. Lancet 386, 541\u2013551 (2015).","journal-title":"Lancet"},{"key":"63791_CR21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jdermsci.2019.06.007","volume":"95","author":"M Kishibe","year":"2019","unstructured":"Kishibe, M. Physiological and pathological roles of kallikrein-related peptidases in the epidermis. J. Dermatol. Sci. 95, 50\u201355 (2019).","journal-title":"J. Dermatol. Sci."},{"key":"63791_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s13679-020-00380-3","volume":"9","author":"K Paroutoglou","year":"2020","unstructured":"Paroutoglou, K., Papadavid, E., Christodoulatos, G. S. & Dalamaga, M. Deciphering the association between psoriasis and obesity: Current evidence and treatment considerations. Curr. Obes. Rep. 9, 165\u2013178 (2020).","journal-title":"Curr. Obes. Rep."},{"key":"63791_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1309549","volume":"14","author":"Q Li","year":"2023","unstructured":"Li, Q. et al. Large-scale epidemiological analysis of common skin diseases to identify shared and unique comorbidities and demographic factors. Front. Immunol. 14, 1309549 (2023).","journal-title":"Front. Immunol."},{"key":"63791_CR24","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.dsx.2019.01.009","volume":"13","author":"M Mamizadeh","year":"2019","unstructured":"Mamizadeh, M., Tardeh, Z. & Azami, M. The association between psoriasis and diabetes mellitus: A systematic review and meta-analysis. Diabetes Metab. Syndr. 13, 1405\u20131412 (2019).","journal-title":"Diabetes Metab. Syndr."},{"key":"63791_CR25","doi-asserted-by":"publisher","first-page":"761","DOI":"10.5604\/01.3001.0010.3854","volume":"71","author":"A Owczarczyk-Saczonek","year":"2017","unstructured":"Owczarczyk-Saczonek, A. & Placek, W. Compounds of psoriasis with obesity and overweight. Postepy Hig. Med. Dosw 71, 761\u2013772 (2017).","journal-title":"Postepy Hig. Med. Dosw"},{"key":"63791_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112704","volume":"139","author":"L Yan","year":"2024","unstructured":"Yan, L. et al. Role of glucose metabolism reprogramming in keratinocytes in the link between psoriasis and metabolic syndrome. Int. Immunopharmacol. 139, 112704 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"63791_CR27","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang, D. et al. Metabolic regulation of gene expression by histone lactylation. Nature 574, 575\u2013580 (2019).","journal-title":"Nature"},{"key":"63791_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41589-024-01680-8","volume":"21","author":"D Zhang","year":"2025","unstructured":"Zhang, D. et al. Lysine L-lactylation is the dominant lactylation isomer induced by glycolysis. Nat. Chem. Biol. 21, 91\u201399 (2025).","journal-title":"Nat. Chem. Biol."},{"key":"63791_CR29","first-page":"S289","volume":"180","author":"SPH Alexander","year":"2023","unstructured":"Alexander, S. P. H. et al. The concise guide to PHARMACOLOGY 2023\/24: Enzymes. Br. J. Pharm. 180, S289\u2013S373 (2023).","journal-title":"Br. J. Pharm."},{"key":"63791_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-023-02931-y","volume":"24","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. YY1 lactylation in microglia promotes angiogenesis through transcription activation-mediated upregulation of FGF2. Genome Biol. 24, 87 (2023).","journal-title":"Genome Biol."},{"key":"63791_CR31","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1161\/CIRCRESAHA.122.320488","volume":"131","author":"N Wang","year":"2022","unstructured":"Wang, N. et al. Histone Lactylation Boosts Reparative Gene Activation Post-Myocardial Infarction. Circ. Res. 131, 893\u2013908 (2022).","journal-title":"Circ. Res."},{"key":"63791_CR32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2314128121","volume":"121","author":"B Xie","year":"2024","unstructured":"Xie, B. et al. KAT8-catalyzed lactylation promotes eEF1A2-mediated protein synthesis and colorectal carcinogenesis. Proc. Natl. Acad. Sci. USA 121, e2314128121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"63791_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28966","volume":"95","author":"L Zhao","year":"2023","unstructured":"Zhao, L. et al. HBV confers innate immune evasion through triggering HAT1\/acetylation of H4K5\/H4K12\/miR-181a-5p or KPNA2\/cGAS-STING\/IFN-I signaling. J. Med. Virol. 95, e28966 (2023).","journal-title":"J. Med. Virol."},{"key":"63791_CR34","doi-asserted-by":"publisher","first-page":"5319","DOI":"10.1038\/sj.onc.1210602","volume":"26","author":"MR Parthun","year":"2007","unstructured":"Parthun, M. R. Hat1: the emerging cellular roles of a type B histone acetyltransferase. Oncogene 26, 5319\u20135328 (2007).","journal-title":"Oncogene"},{"key":"63791_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39101-4","volume":"14","author":"Q Xu","year":"2023","unstructured":"Xu, Q. et al. ACL and HAT1 form a nuclear module to acetylate histone H4K5 and promote cell proliferation. Nat. Commun. 14, 3265 (2023).","journal-title":"Nat. Commun."},{"key":"63791_CR36","doi-asserted-by":"crossref","unstructured":"Ziogas, A. et al. Long-term histone lactylation connects metabolic and epigenetic rewiring in innate immune memory. Cell (2025).","DOI":"10.1016\/j.cell.2025.03.048"},{"key":"63791_CR37","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1146\/annurev.biochem.76.052705.162114","volume":"76","author":"MD Shahbazian","year":"2007","unstructured":"Shahbazian, M. D. & Grunstein, M. Functions of site-specific histone acetylation and deacetylation. Annu. Rev. Biochem. 76, 75\u2013100 (2007).","journal-title":"Annu. Rev. Biochem."},{"key":"63791_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2025.108262","volume":"301","author":"RN Sengupta","year":"2025","unstructured":"Sengupta, R. N. et al. Modulation of the substrate preference of a MYST acetyltransferase by a scaffold protein. J. Biol. Chem. 301, 108262 (2025).","journal-title":"J. Biol. Chem."},{"key":"63791_CR39","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1021\/acs.accounts.2c00115","volume":"55","author":"C Moreno-Yruela","year":"2022","unstructured":"Moreno-Yruela, C., Baek, M., Monda, F. & Olsen, C. A. Chiral posttranslational modification to Lysine epsilon-amino groups. Acc. Chem. Res. 55, 1456\u20131466 (2022).","journal-title":"Acc. Chem. Res."},{"key":"63791_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06706-6","volume":"15","author":"P Zhang","year":"2024","unstructured":"Zhang, P. et al. FBP1 orchestrates keratinocyte proliferation\/differentiation and suppresses psoriasis through metabolic control of histone acetylation. Cell Death Dis. 15, 392 (2024).","journal-title":"Cell Death Dis."},{"key":"63791_CR41","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.immuni.2024.04.022","volume":"57","author":"I Subudhi","year":"2024","unstructured":"Subudhi, I. et al. Metabolic coordination between skin epithelium and type 17 immunity sustains chronic skin inflammation. Immunity 57, 1665\u20131680 (2024).","journal-title":"Immunity"},{"key":"63791_CR42","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.cmet.2019.10.004","volume":"30","author":"V Pucino","year":"2019","unstructured":"Pucino, V. et al. Lactate buildup at the site of chronic inflammation promotes disease by inducing CD4(+) T cell metabolic rewiring. Cell Metab. 30, 1055\u20131074 (2019).","journal-title":"Cell Metab."},{"key":"63791_CR43","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/s44318-024-00039-y","volume":"43","author":"U Ayyangar","year":"2024","unstructured":"Ayyangar, U. et al. Metabolic rewiring of macrophages by epidermal-derived lactate promotes sterile inflammation in the murine skin. EMBO J. 43, 1113\u20131134 (2024).","journal-title":"EMBO J."},{"key":"63791_CR44","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.devcel.2025.01.007","volume":"60","author":"Z Li","year":"2025","unstructured":"Li, Z. et al. Lactate shuttling links histone lactylation to adult hippocampal neurogenesis in mice. Dev. Cell 60, 1271\u20131273 (2025).","journal-title":"Dev. Cell"},{"key":"63791_CR45","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adc9465","volume":"9","author":"M Fan","year":"2023","unstructured":"Fan, M. et al. Lactate promotes endothelial-to-mesenchymal transition via Snail1 lactylation after myocardial infarction. Sci. Adv. 9, eadc9465 (2023).","journal-title":"Sci. Adv."},{"key":"63791_CR46","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/iub.572","volume":"64","author":"AP Halestrap","year":"2012","unstructured":"Halestrap, A. P. & Wilson, M. C. The monocarboxylate transporter family\u2014role and regulation. IUBMB Life 64, 109\u2013119 (2012).","journal-title":"IUBMB Life"},{"key":"63791_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/iub.573","volume":"64","author":"AP Halestrap","year":"2012","unstructured":"Halestrap, A. P. The monocarboxylate transporter family\u2014Structure and functional characterization. IUBMB Life 64, 1\u20139 (2012).","journal-title":"IUBMB Life"},{"key":"63791_CR48","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10863-012-9428-1","volume":"44","author":"C Pinheiro","year":"2012","unstructured":"Pinheiro, C. et al. Role of monocarboxylate transporters in human cancers: state of the art. J. Bioenerg. Biomembr. 44, 127\u2013139 (2012).","journal-title":"J. Bioenerg. Biomembr."},{"key":"63791_CR49","doi-asserted-by":"publisher","first-page":"e1579","DOI":"10.1590\/0102-672020210001e1579","volume":"34","author":"R De-Cleva","year":"2021","unstructured":"De-Cleva, R., Cardia, L., Vieira-Gadducci, A., Greve, J. M. & Santo, M. A. Lactate can be a marker of metabolic syndrome in severe obesity?. Arq. Bras. Cir. Dig. 34, e1579 (2021).","journal-title":"Arq. Bras. Cir. Dig."},{"key":"63791_CR50","doi-asserted-by":"crossref","unstructured":"Ding, Y. et al. Tyrosine phosphatase SHP2 exacerbates psoriasis-like skin inflammation in mice via ERK5-dependent NETosis. Medcomm 3, (2022).","DOI":"10.1002\/mco2.120"},{"key":"63791_CR51","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1080\/15548627.2020.1725381","volume":"17","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. Autophagy-based unconventional secretion of HMGB1 by keratinocytes plays a pivotal role in psoriatic skin in fl ammation. Autophagy 17, 529\u2013552 (2021).","journal-title":"Autophagy"},{"key":"63791_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.104895","volume":"299","author":"C Luan","year":"2023","unstructured":"Luan, C. et al. PCSK9 inhibition interrupts the cross-talk between keratinocytes and macrophages and prevents UVB-induced skin damage. J. Biol. Chem. 299, 104895 (2023).","journal-title":"J. Biol. Chem."},{"key":"63791_CR53","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.7150\/thno.89180","volume":"14","author":"W Jiang","year":"2024","unstructured":"Jiang, W. et al. Keratinocyte-to-macrophage communication exacerbate psoriasiform dermatitis via LRG1-enriched extracellular vesicles. Theranostics 14, 1049\u20131064 (2024).","journal-title":"Theranostics"},{"key":"63791_CR54","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1016\/j.immuni.2024.09.002","volume":"57","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. The transcription regulators ZNF750 and LSD1\/KDM1A dampen inflammation on the skin\u2019s surface by silencing pattern recognition receptors. Immunity 57, 2296\u20132309.e2295 (2024).","journal-title":"Immunity"},{"key":"63791_CR55","doi-asserted-by":"publisher","first-page":"6019","DOI":"10.1039\/D2SC00918H","volume":"13","author":"Y Sun","year":"2022","unstructured":"Sun, Y., Chen, Y. & Peng, T. A bioorthogonal chemical reporter for the detection and identification of protein lactylation. Chem. Sci. 13, 6019\u20136027 (2022).","journal-title":"Chem. Sci."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63791-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63791-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63791-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:03:09Z","timestamp":1759622589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63791-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["63791"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-63791-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"14 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8639"}}